Veglin research being conducted at University -- MesoLink.org -- 02-16-05

New drug called veglin is being tested by researchers at the University of Southern California. The drug has so far shown promising results, and researchers state that it can stop cancer cells from producing VEGF (Vascular Endothelial Growth Factor). This is a chemical that cancer cells use to grow, and the effect of the drug on this chemical has given researchers and test patients, high hopes.

The trial relating to veglin is still in its early stages, so no conclusions can yet be drawn. However, preliminary testing shows a very promising outlook, and both researchers and patients are optimistic. In fact, one patient suffering from mesothelioma – a deadly form of cancer that results from exposure to asbestos – claims that the results of veglin have been astounding, and that growth has stopped since he was treated with this drug.

The drug was tested on a variety of patients with advanced or hard to treat cancer, and overall around 56 percent showed signs of improvement with tumor growth slowing down. With regards to the possible side effects of this drug, the only side effect reported during testing so far is feverishness. Testing and research will continue on this drug, and it is hoped that continual research will confirm its effectiveness and safety.